Advanced search×

Novel approaches to cancer therapy using oncolytic viruses.

Curr Mol Med 3(1):61-71 (2003) PMID 12558075

The goal of oncolytic therapy is to exploit the innate ability of viruses to infect tumor cells, replicate in tumor cells, and produce selective oncolysis while sparing normal cells. Although the concept that viruses can be oncolytic is not new, it is only in the last three decades that efforts have been directed at genetically mutating viruses to specifically target characteristics of cancer cells. Several viruses have the potential to infect, replicate and lyse tumor cells, each taking advantage of different host cancer cell biology. This review will focus on the major viruses under current investigation for oncolytic therapy, the mechanism by which they specifically eradicate tumors, and the clinical strategies currently under investigation.

Version: za2963e q8zaa q8zb7 q8zc6 q8zd9 q8ze9 q8zf9 q8zga

Similar articles you may find interesting…

  1. BRAF V600E mutation detection by immunohistochemistry in colorectal carcinoma.

    Genes Chromosomes Cancer (2013) PMID 23650027

    The serine/threonine-protein kinase B-raf (BRAF) is an oncogene mutated in various neoplasms, including 5-15% of colorectal carcinomas. The T1799A point mutation, responsible for a large majority of these alterations, results in an amino acid substitution (V600E) causing the constitu...
  2. Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer.

    Clin Cancer Res (2013) PMID 23649003

    Seventy-four of 113 (65.4%) and 24 of 71 (33.8%) were progression free after 4 cycles of CD and EP, respectively. Median overall survival (OS) was 16 months (95% CI, 13.6-19.0 months). Of the 7 "anaplastic" criteria, bulky tumor mass was significantly associated with poor outcome. Lactic acid dehydr...
  3. Cytomegalovirus UL97 Kinase Catalytic Domain Mutations that Confer Multi-Drug Resistance.

    Antimicrob Agents Chemother (2013) PMID 23650173

    Human cytomegalovirus UL97 kinase mutations that commonly confer ganciclovir resistance cluster in different parts of the gene than those conferring resistance to maribavir, an experimental UL97 kinase inhibitor. The drug resistance, growth and autophosphorylation phenotypes of sever...